Use of mangiferin as a non-drug phytotherapy strategy in the treatment of type 2 diabetes mellitus: an integrative review

Mangifera Indica Linn is the scientific name for the popularly known mango, and this plant contains many beneficial properties for health. Humans are able to use its leaves, extract, trunk bark, because it contains an active substance named mangiferin which has numerous medicinal properties. As it i...

Descripción completa

Detalles Bibliográficos
Autores: Medeiros, Juliana de Souza dos Santos, Brandão, Thaynara Lays Sales, Freitas , Maria Eduarda Tavares de, Silva , Júlia Carolina Lopes, Campos, Sarah Évelin Dias, Francelino, Jakeline Olindina
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Brasil
Institución:Universidade Federal de Itajubá (UNIFEI)
Repositorio:Research, Society and Development
Idioma:portugués
OAI Identifier:oai:ojs.pkp.sfu.ca:article/32318
Acceso en línea:https://rsdjournal.org/index.php/rsd/article/view/32318
Access Level:acceso abierto
Palabra clave:Type 2, diabetes mellitus
Phytotherapeutic Drugs
Mangifera
Plants, Medicinal.
Diabetes mellitus tipo 2
Medicamentos fitoterápicos
Plantas medicinales.
Medicamentos Fitoterápicos
Plantas medicinais.
Descripción
Sumario:Mangifera Indica Linn is the scientific name for the popularly known mango, and this plant contains many beneficial properties for health. Humans are able to use its leaves, extract, trunk bark, because it contains an active substance named mangiferin which has numerous medicinal properties. As it is a natural and low-cost product for consumers, it can be a complementary herbal medicine strategy for several pathologies, including Type 2 Diabetes Mellitus (DM2). Mangiferin has several properties as antioxidant, antidiabetic, anticancer, anti-inflammatory, antitumor, antiviral, anthelmintic, antibacterial, antihypertensive, among other chronic non-communicable diseases. General objective: describe the main findings in the literature about the use of the herbal medicine of mangiferin in the prevention and/or treatment of DM2. Methodology: an integrative review was adopted, through the PICO strategy, including research in Portuguese and English available in several scientific databases on the platforms: Scielo, PubMed, Sciencedirect. Results: data obtained from literature suggest the use of mangiferin as a prophylactic strategy in the auxiliary treatment of DM2, which can enhance the reduction in the consumption of industrialized drugs, as well as in the prevention of diseases. Conclusion: through the integrative review, it was possible to identify that mangiferin demonstrates a great potential in the treatment not only of DM2, as well as in other chronic non-communicable diseases.